SVP CMC and Development, Crescendo Biologics Ltd
Richard has over 20 years’ experience in the biopharmaceutical industry, in particular in CMC project management and development of monoclonal antibody-based products. Prior to joining Crescendo, Richard was VP CMC at Kymab Ltd, where he established their internal CMC development functions and managed a network of contract manufacturing organisations. Richard has also held senior positions at Crucell (Janssen vaccines), CAT/Medimmune, Acambis and Schering Plough Animal Health. Richard received his PhD from the University of Surrey, Guildford, UK.
20 May 2021
CATCH UP ON DEMAND